Sue Gail Eckhardt is a director of Exelixis Inc.
Person profile
Roles
Exelixis
Director
Syros Pharmaceuticals
Director
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Jan 24 | EXEL Exelixis | Common Stock | Grant | Acquire A | No | No | 0 | 15,424 | 0.00 | 15,424 |
5 Jan 24 | EXEL Exelixis | Option Common Stock | Grant | Acquire A | No | No | 23.24 | 30,848 | 716.91 k | 30,848 |
1 Jun 23 | SYRS Syros Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 4,000 | 0.00 | 12,000 |
1 Jun 23 | SYRS Syros Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 3.7 | 6,000 | 22.20 k | 6,000 |